NR 601 PRIMARY CARE ADULT &
GERIATRIC PATIENT FINAL EXAM
ACTUAL 2026/2027 - COMPLETE
LATEST MOCK PRACTICE SET
188 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NR 601 PRIMARY CARE ADULT & GERIATRIC PATIENT FINAL EXAM ACTUAL 2026/2027 - COMPLETE
EXAM-STYLE QUESTIONS | 100% VERIFIED - PASS GUARANTEED - A+ GRADED. It contains 188 carefully
selected questions that reflect the most current exam content and testing strategies. Each question is
accompanied by a correct answer and a detailed rationale that explains the underlying pathophysiology,
pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 188 Questions
Foundations - Application - NR 601 Primary CARE Adult & Geriatric Patient Actual 2026/2027 Complete
-style 100 PASS Guaranteed A Primary CARE Adult AND Geriatric Patient Management Graduate Nurse
Practitioner Program
All answers with rationales
,Table of Contents
Section A - Appropriate Section B - Chronic
Questions 1 to 47 Questions 48 to 94
Section C - Disease Section D - Older
Questions 95 to 141 Questions 142 to 188
,Section A - Appropriate
Q1.
A patient with type 2 diabetes and stage 3 chronic kidney disease (eGFR 45 mL/min) is on
metformin, lisinopril, and atorvastatin. Recent labs show HbA1c 8.2%, BP 138/86 mmHg,
and LDL 110 mg/dL. Which medication adjustment is most appropriate?
A. Add dapagliflozin to improve glycemic B. Increase metformin dose to maximum to
control and provide cardiovascular and renal achieve HbA1c target.
benefits.
C. Switch atorvastatin to rosuvastatin 40 mg D. Add amlodipine to intensify blood
for further LDL reduction. pressure control.
Correct: A - Add dapagliflozin to improve glycemic control and provide cardiovascular
and renal benefits.
Rationale:In patients with T2DM, CKD, and ASCVD risk, SGLT2 inhibitors like dapagliflozin
are recommended for glycemic control, cardiovascular risk reduction, and slowing CKD
progression. Metformin is already at a reasonable dose and may be limited by renal function.
Rosuvastatin 40 mg is not the preferred intensification; adding ezetimibe or PCSK9 inhibitor
would be considered. Amlodipine could be added for BP but does not address glycemic or
renal outcomes.
Q2.
Which of the following best explains the increased risk of falls in older adults who are
prescribed multiple psychotropic medications?
A. Orthostatic hypotension and sedation due B. Increased bone resorption due to
to anticholinergic and alpha-adrenergic hyperprolactinemia.
antagonism.
C. Impaired visual accommodation due to D. Reduced proprioception due to peripheral
muscarinic blockade. neuropathy.
Correct: A - Orthostatic hypotension and sedation due to anticholinergic and
alpha-adrenergic antagonism.
Rationale:Psychotropics (e.g., benzodiazepines, antipsychotics, TCAs) cause orthostatic
hypotension and sedation via alpha-adrenergic and histaminergic antagonism, increasing fall
risk. Hyperprolactinemia affects bone but not directly falls. Visual accommodation and
proprioception are not primary mechanisms for psychotropic-induced falls.
Page 3
, Section A - Appropriate
Q3.
A patient with chronic heart failure with reduced ejection fraction (HFrEF) is on
sacubitril/valsartan, carvedilol, spironolactone, and furosemide. Which lab finding
requires immediate intervention?
A. Potassium 5.6 mEq/L B. BNP 500 pg/mL
C. eGFR 58 mL/min/1.73m² D. Hemoglobin 11.5 g/dL
Correct: A - Potassium 5.6 mEq/L
Rationale:Hyperkalemia (K >5.5) is a critical concern with sacubitril/valsartan and
spironolactone; it increases risk of arrhythmias and requires immediate action (hold
spironolactone, adjust other meds). BNP elevation is expected in HF, eGFR 58 is acceptable,
and mild anemia is not an emergency.
Q4.
In a patient with COPD and frequent exacerbations despite triple therapy, which additional
intervention has been shown to reduce exacerbations?
A. Long-term azithromycin B. Regular oral corticosteroids
C. High-dose inhaled corticosteroids alone D. Supplemental oxygen at rest
Correct: A - Long-term azithromycin
Rationale:Long-term macrolide therapy (azithromycin) reduces exacerbations in selected
COPD patients with recurrent exacerbations. Chronic oral corticosteroids are not
recommended due to side effects. Inhaled corticosteroids alone are not as effective as triple
therapy. Oxygen is for hypoxemia, not exacerbation prevention.
Q5.
Which of the following is the most appropriate first-line treatment for a patient with newly
diagnosed osteoporosis (T-score -2.8) and a history of upper GI bleeding on NSAIDs?
A. Alendronate B. Risedronate
C. Teriparatide D. Denosumab
Correct: D - Denosumab
Rationale:Denosumab is a non-oral option that avoids GI side effects and is appropriate for
patients with contraindications to oral bisphosphonates (e.g., GI bleeding). Alendronate and
risedronate are oral and may worsen GI issues. Teriparatide is reserved for severe or those
who fail other therapies.
Page 4
GERIATRIC PATIENT FINAL EXAM
ACTUAL 2026/2027 - COMPLETE
LATEST MOCK PRACTICE SET
188 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
NR 601 PRIMARY CARE ADULT & GERIATRIC PATIENT FINAL EXAM ACTUAL 2026/2027 - COMPLETE
EXAM-STYLE QUESTIONS | 100% VERIFIED - PASS GUARANTEED - A+ GRADED. It contains 188 carefully
selected questions that reflect the most current exam content and testing strategies. Each question is
accompanied by a correct answer and a detailed rationale that explains the underlying pathophysiology,
pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 188 Questions
Foundations - Application - NR 601 Primary CARE Adult & Geriatric Patient Actual 2026/2027 Complete
-style 100 PASS Guaranteed A Primary CARE Adult AND Geriatric Patient Management Graduate Nurse
Practitioner Program
All answers with rationales
,Table of Contents
Section A - Appropriate Section B - Chronic
Questions 1 to 47 Questions 48 to 94
Section C - Disease Section D - Older
Questions 95 to 141 Questions 142 to 188
,Section A - Appropriate
Q1.
A patient with type 2 diabetes and stage 3 chronic kidney disease (eGFR 45 mL/min) is on
metformin, lisinopril, and atorvastatin. Recent labs show HbA1c 8.2%, BP 138/86 mmHg,
and LDL 110 mg/dL. Which medication adjustment is most appropriate?
A. Add dapagliflozin to improve glycemic B. Increase metformin dose to maximum to
control and provide cardiovascular and renal achieve HbA1c target.
benefits.
C. Switch atorvastatin to rosuvastatin 40 mg D. Add amlodipine to intensify blood
for further LDL reduction. pressure control.
Correct: A - Add dapagliflozin to improve glycemic control and provide cardiovascular
and renal benefits.
Rationale:In patients with T2DM, CKD, and ASCVD risk, SGLT2 inhibitors like dapagliflozin
are recommended for glycemic control, cardiovascular risk reduction, and slowing CKD
progression. Metformin is already at a reasonable dose and may be limited by renal function.
Rosuvastatin 40 mg is not the preferred intensification; adding ezetimibe or PCSK9 inhibitor
would be considered. Amlodipine could be added for BP but does not address glycemic or
renal outcomes.
Q2.
Which of the following best explains the increased risk of falls in older adults who are
prescribed multiple psychotropic medications?
A. Orthostatic hypotension and sedation due B. Increased bone resorption due to
to anticholinergic and alpha-adrenergic hyperprolactinemia.
antagonism.
C. Impaired visual accommodation due to D. Reduced proprioception due to peripheral
muscarinic blockade. neuropathy.
Correct: A - Orthostatic hypotension and sedation due to anticholinergic and
alpha-adrenergic antagonism.
Rationale:Psychotropics (e.g., benzodiazepines, antipsychotics, TCAs) cause orthostatic
hypotension and sedation via alpha-adrenergic and histaminergic antagonism, increasing fall
risk. Hyperprolactinemia affects bone but not directly falls. Visual accommodation and
proprioception are not primary mechanisms for psychotropic-induced falls.
Page 3
, Section A - Appropriate
Q3.
A patient with chronic heart failure with reduced ejection fraction (HFrEF) is on
sacubitril/valsartan, carvedilol, spironolactone, and furosemide. Which lab finding
requires immediate intervention?
A. Potassium 5.6 mEq/L B. BNP 500 pg/mL
C. eGFR 58 mL/min/1.73m² D. Hemoglobin 11.5 g/dL
Correct: A - Potassium 5.6 mEq/L
Rationale:Hyperkalemia (K >5.5) is a critical concern with sacubitril/valsartan and
spironolactone; it increases risk of arrhythmias and requires immediate action (hold
spironolactone, adjust other meds). BNP elevation is expected in HF, eGFR 58 is acceptable,
and mild anemia is not an emergency.
Q4.
In a patient with COPD and frequent exacerbations despite triple therapy, which additional
intervention has been shown to reduce exacerbations?
A. Long-term azithromycin B. Regular oral corticosteroids
C. High-dose inhaled corticosteroids alone D. Supplemental oxygen at rest
Correct: A - Long-term azithromycin
Rationale:Long-term macrolide therapy (azithromycin) reduces exacerbations in selected
COPD patients with recurrent exacerbations. Chronic oral corticosteroids are not
recommended due to side effects. Inhaled corticosteroids alone are not as effective as triple
therapy. Oxygen is for hypoxemia, not exacerbation prevention.
Q5.
Which of the following is the most appropriate first-line treatment for a patient with newly
diagnosed osteoporosis (T-score -2.8) and a history of upper GI bleeding on NSAIDs?
A. Alendronate B. Risedronate
C. Teriparatide D. Denosumab
Correct: D - Denosumab
Rationale:Denosumab is a non-oral option that avoids GI side effects and is appropriate for
patients with contraindications to oral bisphosphonates (e.g., GI bleeding). Alendronate and
risedronate are oral and may worsen GI issues. Teriparatide is reserved for severe or those
who fail other therapies.
Page 4
